Request an Invitation
CardioExchange has 4,598 members
TRILOGY at ESC: No Advantage for Prasugrel Over Clopidogrel in Medical ACS Patients
The newer antiplatelet agent prasugrel was no better than the old standby clopidogrel for treating patients with acute coronary syndrome (ACS) who are...
To continue reading, please log in to the right or
request an invitation
Member Sign In
Stay Signed In
Forgot your password?
Request an invitation
to become a CardioExchange member.
Copyrighted © 2013, Massachusetts Medical Society
The content of this site is intended for health care professionals.